Andrew H Limper MD
Critical Care Medicine, Pleural Disease
Professor, Internal Medicine, Mayo Medical School
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Limper is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1989- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1986
University of Illinois College of MedicineClass of 1984
Certifications & Licensure
MN State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014-2017
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Publications & Presentations
PubMed
- Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.Kathryn T Del Valle, Kayla J Kolbert, Kaitlin J Sikkink, Chloe E Gill, Jennifer L Kemppainen
Mayo Clinic Proceedings. 2026-07-02 - Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD Research.Jeffrey M Sturek, John S Kim, Anna Podolanczuk, Riley T Hannan, Andrew H Limper
American Journal of Respiratory and Critical Care Medicine. 2026-07-01 - Extracorporeal Membrane Oxygenation for Pneumocystis Pneumonia: Outcomes in Patients From the Extracorporeal Life Support Organization.Kyle J Henry, Emily R Thompson, Kealy Ham, Holenarasipur R Vikram, Rodrigo Cartin-Ceba
Critical Care Explorations. 2026-05-01
Abstracts/Posters
- Incidence and Outcomes of Pneumocystis pneumonia When Utilizing PCR-Based Diagnosis in Patients with Hodgkin Lymphoma Receiving Intensive ChemotherapyAndrew H Limper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Other
- Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patientsLimper AH, Thomas CF
http://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-pneumocystis-
UpToDate, Wolters Kluwer Health - 2013-02-27 - Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patientsLimper AH, Thomas CF
http://www.uptodate.com/contents/treatment-and-prevention-of-pneumocystis-pneumonia-in-non-hiv-infec
UpToDate, Wolters Kluwer Health - 2013-02-27 - Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agentsLimper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-antineoplastic-therapy-cytotoxic
UpToDate, Wolters Kluwer Health - 2013-03-28
Press Mentions
Fernando Martinez Leading Nationwide DOD Clinical Study Targeting Idiopathic Pulmonary FibrosisOctober 16th, 2025- Fungal Infections Are Becoming More Frequent. Why Isn't There a Vaccine?February 10th, 2023
- Fungal Infections Are Becoming More Common. Why Isn’t There a Vaccine?February 10th, 2023
Grant Support
- Pneumocystis: Macrophage & Epithelial ActivationMAYO CLINIC ROCHESTER1993–2027
- Pneumocystis: Macrophage & Epithelial ActivationMAYO CLINIC ROCHESTER1993–2027
- The Role of the EphA2 Receptor Kinase Pathway in Pneumocystis Pneumonia (PCP)MAYO CLINIC ROCHESTER2023–2025
- Cholesterol And Sphingolipid Perturbation Of Membrane Traffic In Human DiseaseNational Institute Of General Medical Sciences2010–2011
- Control Of The Pneumocystis Carinii Life CycleNational Heart, Lung, And Blood Institute2004–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
